James WiseOur investment in Kaia Health: tackling chronic pain one phone at a timeWorking in technology, you see plenty of graphs. But one graph bothers me more above all of them:Jan 21, 2019Jan 21, 2019
James WiseinBaldertonSophia Genetics announces new $77M funding roundAfter a very strong 2018 for our portfolio company Sophia Genetics, in which they achieved many technical and commercial firsts, we are…Jan 4, 2019Jan 4, 2019
James WiseinBaldertonAnnouncing our investment in PusherToday its a pleasure to announce our latest investment into Pusher, alongside Heavybit and Passion Capital.Apr 25, 2018Apr 25, 2018
James WiseWhy the UK shouldn’t be afraid of regulating bigtech — because we’re good at itSyndicated in The Sunday Telegraph ( 18/03/2018)Mar 22, 2018Mar 22, 2018
James WiseinBaldertonWhy 2018 could be the software industry’s ‘seatbelt’ momentAs syndicated in Venturebeat.comJan 8, 20181Jan 8, 20181
James WiseinBaldertonWhy we’ve invested in Sophia Genetics ( and why the world is obsessed with your genome)TL:DR Genetics is a software problem, and there’s plenty of problems to be solvedSep 13, 2017Sep 13, 2017
James WiseFeeling Disenfranchised? There are apps for that.The technology designed to make us better citizensJul 8, 2016Jul 8, 2016
James WiseThe European ‘Series A’ crunch is gone, so what does the future hold for the Class of ‘15?After years of complaints about there being a ‘Series A’ crunch, Europe has resolutely turned a corner with a reported 338 of the 1,000+…Dec 10, 20151Dec 10, 20151
James WiseinBaldertonDealing with investors without losing your mind: An email templateThis is a follow-up post to ‘The Funding Round is Dead’Sep 8, 20152Sep 8, 20152
James WiseIgnore the snobs: Crowdfunding is bringing diversity to businessHow crowdfunding is helping those increasingly locked out of ownershipAug 11, 20151Aug 11, 20151
